Ulteriori informazioni
The kidneys, vital for filtering the body's waste, are highly vulnerable to drug-induced nephrotoxicity, a leading cause of acute kidney injury (AKI) in hospitalized patients, with up to 60% of cases linked to medications such as antibiotics, chemotherapy, and analgesics. This book addresses the urgent need to balance pharmacological innovation with kidney protection. Recent advances have deepened understanding of nephrotoxicity, revealing complex molecular, genetic, and biomarker-driven mechanisms, while multi-drug regimens and aging populations add further complexity. Designed for clinicians, researchers, and trainees, the text covers epidemiology, pathophysiology, high-risk drug classes, diagnostic tools (including biomarkers like KIM-1 and cystatin C), and prevention strategies, illustrated by case studies and the "6R's of Nephrotoxicity" framework. Collaborative and interdisciplinary, it emphasizes stewardship, vigilant monitoring, and patient education. The book also explores future directions, such as genomic risk prediction, AI-driven pharmacovigilance, and equitable kidney care, aiming to inspire a commitment to safe prescribing and renal stewardship.
Info autore
Dr. Lalit Mohan Nainwal, Assistant Professor at KIET Group of Institutions, Delhi-NCR, Ghaziabad, India and holds a PhD from Jamia Hamdard, with 8+ years' experience. He has published 32+ papers, 1 textbook, 3 book chapters, 875+ citations, H-index 16. Research Interest: Anticancer, Anti-Inflammatory Agents, Computer Aided Drug Design.
